74996 Federal Register / Vol. 88, No. 210 / Wednesday, November 1, 2023 / Notices 

pertaining to conditions in the ocean 

freight delivery system to the 

Commission. Specifically, the 

Committee advises the Federal Maritime 

Commission on policies relating to the 

competitiveness, reliability, integrity, 

and fairness of the international ocean 

freight delivery system. 46 U.S.C. 

42502(b). 

The Committee will receive an update 

from each of its subcommittees. The 

Committee may receive proposals for 

recommendations to the Federal 

Maritime Commission and may vote on 

these recommendations. Any proposed 

recommendations will be available for 

the public to view in advance of the 

meeting on the NSAC’s website, https:// 

www.fmc.gov/industry-oversight/ 

national-shipper-advisory-committee/. 

Public Comments: Members of the 

public may submit written comments to 

NSAC at any time. Comments should be 

addressed to NSAC, c/o Dylan 

Richmond, Federal Maritime 

Commission, 800 North Capitol St. NW, 

Washington, DC 20573 or nsac@

fmc.gov. 

The Committee will also take public 

comment at its meeting. If attending the 

meeting in person and providing 

comments, please note that in the 

registration request. Comments are most 

helpful if they address the Committee’s 

objectives or their proposed 

recommendations. Comments at the 

meeting will be limited to 3 minutes 

each. 

A copy of all meeting documentation, 

including meeting minutes, will be 

available at www.fmc.gov following the 

meeting. 

By the Commission. 

Dated: October 27, 2023. 

Carl Savoy, 

Federal Register Alternate Liaison Officer. 

[FR Doc. 2023–24072 Filed 10–31–23; 8:45 am] 

BILLING CODE 6730–02–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than November 16, 2023. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, IL 60604) [Colette.A.Fried@

chi.frb.org]: 

1. Andrew L. Prather and Tina 

Prather, both of Petersburg, Illinois; 

Elizabeth A. Prather, Virginia, Illinois; 

and Laura J. Prather, individually and 

as trustee of the Laura J. Prather Trust, 

both of Creve Coeur, Missouri; to join 

the Prather Family Control Group, a 

group acting in concert, to retain voting 

shares of Petefish, Skiles Bancshares, 

Inc., and thereby indirectly retain voting 

shares of Petefish, Skiles & Company, 

both of Virginia, Illinois. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–24122 Filed 10–31–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Healthcare Delivery of 

Clinical Preventive Services for People 

With Disabilities 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Healthcare Delivery of Clinical 

Preventive Services for People with 

Disabilities, which is currently being 

conducted by the AHRQ’s Evidencebased Practice Centers (EPC) Program. 

Access to published and unpublished 

pertinent scientific information will 

improve the quality of this review. 

DATES: Submission Deadline on or 

before December 1, 2023. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Healthcare Delivery of 

Clinical Preventive Services for People 

with Disabilities. AHRQ is conducting 

this review pursuant to section 902 of 

the Public Health Service Act, 42 U.S.C. 

299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Healthcare Delivery of 

Clinical Preventive Services for People 

with Disabilities. The entire research 

protocol is available online at: https://

effectivehealthcare.ahrq.gov/products/ 

people-with-disabilities/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Healthcare Delivery of 

Clinical Preventive Services for People 

with Disabilities helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 210 / Wednesday, November 1, 2023 / Notices 74997 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on topics not included in 

the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://www.effectivehealthcare.

ahrq.gov/email-updates. 

The review will answer the following 

questions. This information is provided 

as background. AHRQ is not requesting 

that the public provide answers to these 

questions. 

Key Questions 

Key Question 1. What are the primary 

barriers and facilitatorsa to the receipt of 

clinical preventive services among 

people with disabilities? 

a. How do these barriers/facilitators 

vary according to preventive service? 

b. How do these barriers/facilitators 

vary according to type and/or severity of 

disability? 

c. How do these barriers/facilitators 

vary according to characteristics such 

as: gender, race/ethnicity, economic 

status, LGBTQ+ status, or geographic 

location? 

Key Question 2. What is the 

effectiveness of interventions to 

improve the receipt of clinical 

preventive services among people with 

disabilities? 

a. How does the effectiveness vary 

according to preventive service? 

b. How does the effectiveness vary 

according to type and/or severity of 

disability? 

c. How does the effectiveness vary 

according to characteristics such as: 

gender, race/ethnicity, economic status, 

LGBTQ+ status, or geographic location? 

Key Question 3. What are the 

characteristics and/or components of 

interventions that contribute to their 

effectiveness (or lack of effectiveness) in 

mitigating barriers to the receipt of 

clinical preventive services among 

people with disabilities? 

a. How does the effectiveness vary 

according to preventive service? 

b. How does the effectiveness vary 

according to type and/or severity of 

disability? 

c. How does the effectiveness vary 

according to characteristics such as: 

gender, race/ethnicity, economic status, 

LGBTQ+ status, or geographic location? 

Key Question 4. What are the harms 

of intervention programs to mitigate 

barriers to the receipt of clinical 

preventive services among people with 

disabilities? 

a. How do the harms vary according 

to preventive service? 

b. How do the harms vary according 

to type and/or severity of disability? 

c. How do the harms vary according 

to characteristics such as: gender, race/ 

ethnicity, economic status, LGBTQ+ 

status, or geographic location? aCategories of barriers and facilitators 

may include but are not limited to: 

• Environment-level (e.g., 

transportation; need/availability of 

guardian or caregiver) 

• Person-level (e.g., fear; discomfort; 

functional ability; self-efficacy) 

• Provider-level (e.g., disability 

knowledge/assumptions; bias or 

‘‘ableism’’; communication skills) 

• Health system (e.g., insurance; 

patient functionality information in 

records; procedural accommodations, 

such as visit length and clinician 

reimbursement) 

• Accessibility of health facilities 

(e.g., physical facility; equipment; 

sensory environment; telehealth) 

• Accessible communication (e.g., 

within facility; from outside of facility) 

• Policy-level (e.g., Federal or State 

laws) 

PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTING) 

Element Include Exclude 

Population ........ • People with disabilities (including: physical; cognitive/intellectual/developmental; sensory; serious psychiatric/mental 

illness) 

• Studies that do not include people with disabilities or do not 

report outcomes according to disability status 

• Adults and children 

• Specific populations of interest: 

—Age 

—Gender 

—Race/ethnicity 

—Economic status 

—LGBTQ+ status 

—Geographic location (regional and urban/rural) 

—Immigration status 

—Incarcerated 

—Unhoused 

—Language spoken 

—Use of a guardian/proxy for healthcare decisions 


ddrumheller on DSK120RN23PROD with NOTICES1
74998 Federal Register / Vol. 88, No. 210 / Wednesday, November 1, 2023 / Notices 

PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTING)—Continued 

Element Include Exclude 

Intervention ....... • Interventions to mitigate barriers and/or improve the receipt 

of clinical preventive services among people with disabilities (e.g., modification in policies, practices, and procedures; effective communication; the physical accessibility of 

facilities; educational/training programs for healthcare providers) 

• Interventions that do not address barriers to receipt of clinical preventive services for people with disabilities 

• Characteristics/components of interventions (KQ3) may include elements such as: staffing, funding, facilities, equipment, training • Preventive services not listed in Appendix B 

• Clinical preventive services listed in Appendix B, derived 

from USPSTF 

Grade A and Grade B recommendations: 

—Screening (anxiety disorders, breast cancer, cervical cancer, colorectal cancer, depression, HIV infection, hypertension, intimate partner violence, osteoporosis, diabetes, 

unhealth drug or alcohol use) 

—Interventions or behavioral counseling (breastfeeding, 

falls prevention, perinatal depression, tobacco use/cessation, weight loss, healthy diet and physical activity, 

sexually transmitted infections) 

Comparator ...... • Another intervention 

• No intervention 

Outcome ........... • Receipt of clinical preventive service • Cost-effectiveness 

• Quality of receipt of clinical preventive service 

• Health outcomes related to clinical preventive service 

• Outcomes not related to included clinical preventive services listed in Appendix B 

• Patient satisfaction 

• Patient well-being 

• Harms of the intervention program 

Timing ............... • All 

Setting .............. • Primary care outpatient clinics 

• Community health clinics 

• Settings referable from primary care settings 

• Emergency departments 

• Other settings (e.g., home, residence, mobile care units) 

• United States or countries with a ‘‘very high’’ United Nations Human Development Index 

Abbreviations: HIV = Human Immunodeficiency Virus; KQ = Key Question; LGBTQ+ = Lesbian Gay Bisexual Transgender Queer/questioning 

plus/others; USPSTF = United States Preventive Services Task Force. 

Dated: October 26, 2023. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2023–24057 Filed 10–31–23; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Privacy Act of 1974; Matching Program 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice of a new matching 

program. 

SUMMARY: In accordance with the 

Privacy Act of 1974, as amended, the 

Department of Health and Human 

Services (HHS), Centers for Medicare & 

Medicaid Services (CMS) is providing 

notice of the re-establishment of a 

computer matching program between 

CMS and the Department of Defense, 

Defense Manpower Data Center for 

‘‘Verification of Eligibility for Minimum 

Essential Coverage Under the Patient 

Protection and Affordable Care Act 

through a Department of Defense Health 

Benefits Plan.’’ 

DATES: The deadline for comments on 

this notice is December 1, 2023. The reestablished matching program will 

commence not sooner than 30 days after 

publication of this notice, provided no 

comments are received that warrant a 

change to this notice. The matching 

program will be conducted for an initial 

term of 18 months (from approximately 

November 30, 2023 to May 29, 2025) 

and within 3 months of expiration may 

be renewed for up to one additional year 

if the parties make no change to the 

matching program and certify that the 

program has been conducted in 

compliance with the matching 

agreement. 

ADDRESSES: Interested parties may 

submit comments on this notice to the 

CMS Privacy Act Officer by mail at: 

Division of Security, Privacy Policy & 

Governance, Information Security & 

Privacy Group, Office of Information 

Technology, Centers for Medicare & 

Medicaid Services, Location: N1–14–56, 

7500 Security Blvd., Baltimore, MD 

21244–1850 or by email at 

Barbara.Demopulos@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about the matching 

program, you may contact Anne Pesto, 

Senior Advisor, Marketplace Eligibility 

and Enrollment Group, Center for 

Consumer Information and Insurance 

Oversight, Centers for Medicare & 

Medicaid Services, at 443–955–9966, by 

email at anne.pesto@cms.hhs.gov, or by 

mail at 7500 Security Blvd., Baltimore, 

MD 21244. 

SUPPLEMENTARY INFORMATION: The 

Privacy Act of 1974, as amended (5 

U.S.C. 552a) provides certain 

protections for individuals applying for 

and receiving Federal benefits. The law 

governs the use of computer matching 

by Federal agencies when records in a 

system of records (meaning, Federal 

agency records about individuals 


ddrumheller on DSK120RN23PROD with NOTICES1